Pharmacotherapy for neuropathic pain in Japan

13Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

Abstract

Neuropathic pain (NeP) results from injury to, or disease of, the peripheral or central components of the neural systems involved in pain. In contrast to inflammatory pain, NeP can persist after healing from the initial injury has resolved. Antipyretic agents, such as non-steroidal anti-inflammatory drugs, steroids, and acetaminophen are ineffective, while specific agents such as gabapentinoids, antidepressants, antiepileptics, and opioids are effective in treating NeP. In this review, we address the definition of NeP, pharmacotherapy for NeP in Japan, pain classification, setting goals for successful NeP medication, and the Japanese algorithm for the pharmacotherapy of NeP with specific prescription guidance.

Cite

CITATION STYLE

APA

Masuda, R., Ajimi, J., & Murata, T. (2017). Pharmacotherapy for neuropathic pain in Japan. Journal of Nippon Medical School. Medical Association of Nippon Medical School. https://doi.org/10.1272/jnms.84.258

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free